Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.30
+0.13 (2.51%)
Jun 27, 2025, 4:08 PM HKT

Sino Biopharmaceutical Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
94,78958,25863,84584,459102,408140,925
Upgrade
Market Cap Growth
-7.15%-8.75%-24.41%-17.53%-27.33%3.10%
Upgrade
Enterprise Value
100,86164,46266,38290,167114,126146,103
Upgrade
Last Close Price
5.303.183.384.345.066.90
Upgrade
PE Ratio
47.4815.6424.8529.375.7142.82
Upgrade
Forward PE
27.3517.4817.7720.6312.3333.15
Upgrade
PS Ratio
3.091.902.212.873.115.02
Upgrade
PB Ratio
2.081.281.521.972.215.29
Upgrade
P/TBV Ratio
2.891.781.962.592.847.22
Upgrade
P/FCF Ratio
15.759.6811.6014.8822.8430.42
Upgrade
P/OCF Ratio
13.478.289.5511.9315.5522.28
Upgrade
PEG Ratio
1.771.241.34-0.623.97
Upgrade
EV/Sales Ratio
3.282.102.303.073.465.20
Upgrade
EV/EBITDA Ratio
13.828.799.4512.7517.0521.73
Upgrade
EV/EBIT Ratio
16.6810.4411.0814.8120.0730.02
Upgrade
EV/FCF Ratio
16.7610.7112.0615.8825.4631.54
Upgrade
Debt / Equity Ratio
0.230.230.330.370.330.63
Upgrade
Debt / EBITDA Ratio
1.391.391.972.222.212.48
Upgrade
Debt / FCF Ratio
1.721.722.542.813.363.64
Upgrade
Asset Turnover
0.450.450.410.420.500.56
Upgrade
Inventory Turnover
2.442.442.312.102.792.93
Upgrade
Quick Ratio
1.111.110.901.151.381.87
Upgrade
Current Ratio
1.261.261.051.291.532.08
Upgrade
Return on Equity (ROE)
11.82%11.82%12.12%11.94%55.25%20.20%
Upgrade
Return on Assets (ROA)
5.62%5.62%5.33%5.40%5.37%6.05%
Upgrade
Return on Capital (ROIC)
7.02%7.02%6.60%6.60%6.69%7.79%
Upgrade
Return on Capital Employed (ROCE)
12.70%12.70%13.30%12.30%10.30%11.30%
Upgrade
Earnings Yield
3.93%6.39%4.02%3.40%17.51%2.33%
Upgrade
FCF Yield
6.35%10.33%8.62%6.72%4.38%3.29%
Upgrade
Dividend Yield
1.51%2.19%1.45%2.76%1.58%1.06%
Upgrade
Payout Ratio
52.76%52.76%27.13%49.84%6.42%42.84%
Upgrade
Buyback Yield / Dilution
2.36%1.26%2.57%1.38%-2.57%0.06%
Upgrade
Total Shareholder Return
3.96%3.45%4.02%4.14%-0.99%1.12%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.